TechNavio today launched its Drug-eluting Stent Market in Europe 2011“2015 report based on an in-depth study focusing exclusively on Europe. The report aims to aid decision makers™ understanding of the present and future landscape of the market.
Commenting on the report, an analyst from TechNavio™s Healthcare team said; Drug-eluting Stent (DES) vendors are opting for strategic alliances as a means of sharing their core competencies to develop innovative products and also to avoid litigation issues. Recently, two leading vendors in the DES market in Europe, Boston Scientific and Abbott Vascular, entered into one such agreement.
According to the report, the prevalence of cardiovascular disease (CVDs) is increasing rapidly in Europe. Over the past decade, as a result of unhealthy dietary habits and lack of physical activity due to hectic lifestyles, there has been an increase in the incidence of diseases such as hypercholesterolemia, coronary heart disease (CHD), and diabetes. This has led to an increase in the demand for catheter-based treatment of heart diseases. Furthermore, the rapidly expanding, aging population is resulting in an increase in the number of people prone to CVD. DES treatment is considered to be more sustainable than treatment using bare-metal stents (BMSs) for the treatment of CHD. Hence, a large number of cardiologists in Europe recommend the use of DESs to patients suffering from CHD to ensure that they receive a good-quality cure. Thus, the increasing number of patients suffering from CVD increases the demand for DESs, and this is expected to help the DES market in Europe expand significantly by 2015.
Further, the report also discusses that the steady decline in the average selling price of DESs has the highest negative impact on the DES market in Europe.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key players.
TechNavio, the market research platform of Infiniti Research Ltd, publishes periodic reports on niche and emerging technologies. For further information, please visit https://www.technavio.com/content/drug-eluting-stent-market-europe-2011-2015
Follow us on Twitter @ Technavio
TechNavio Announces the Publication of its Report “ Drug-eluting Stent Market in Europe 2011“2015
